FNBT
BIO icon

FineMark National Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

FineMark National Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-23
Closed -$3K – 1362
2015
Q3 		$3K Buy
+23
New +$3.31K ﹤0.01% 1164
2013
Q3 		– Sell
-23
Closed -$3K – 1524
2013
Q2 		$3K Buy
+23
New +$2.7K ﹤0.01% 1183

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FineMark National Bank & Trust's BIO Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2015, closing a stake of 23 shares — an estimated $3K sold.

FineMark National Bank & Trust first reported a position in BIO in Q2 2013 and held it in 2 quarters. The position peaked at $3K in Q3 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q4 2015.

  • FineMark National Bank & Trust reported no remaining Bio-Rad Laboratories Class A position as of Q4 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 23 Bio-Rad Laboratories Class A shares in Q4 2015, an estimated $3K.
  • FineMark National Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 2 quarters.
  • FineMark National Bank & Trust's Bio-Rad Laboratories Class A position peaked at $3K in Q3 2015.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.